Pioneering Patient-Centric Formulations
At the heart of UNiFiC PHARMA is our dedicated Research & Development (R&D) framework. Our scientists continuously work on developing novel, highly effective formulations that meet international pharmacopeial standards.
We focus on enhancing dermal penetration, stabilizing sensitive active pharmaceutical ingredients (APIs), and formulating pleasant, non-greasy topical bases to encourage high patient compliance and superior clinical outcomes.
Zone IVb
Climatic StabilityUSP / BP
Monograph Testing
Novel Delivery Systems
Micro-encapsulation and lipid carriers that protect fragile peptides and enhance active dermal absorption.
Zone IVb Stability
Real-time and accelerated stability testing in Zone IVb climatic conditions (30°C/75% RH & 40°C/75% RH) for global export assurance.
Cosmeceutical Science
Developing non-comedogenic, dermatologically tested serums, creams, and sunscreens with high aesthetic elegance.
Pharmacopeial Rigor
Formulation profiles developed in strict compliance with USP, BP, and IP monographs.
Key Formulation Development Focus Areas
Therapeutic priorities driving our current formulation pipeline.
Advanced Ceramide & Barrier Lipid Technology
Re-engineering the stratum corneum barrier matrix for atopic dermatitis, dry skin disorders, and post-procedure recovery.
Multi-Pathway Pigment Depigmenting Agents
Synergistic blends of Tranexamic Acid, Alpha Arbutin, and Kojic Acid targeting epidermal melanogenesis without cytotoxicity.
Broad-Spectrum Photoprotection Formulations
Hybrid photostable UV filters providing SPF 50+ / PA++++ with non-greasy matte textures suitable for Asian and African climates.
Bio-Enhanced Nutraceutical Complexes
High-absorption amino acid chelates, liposomal multivitamins, and herbal standardizations for liver & metabolic support.